Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography: A Randomized Trial

NCT00830193 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT00830193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00830193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography: A Randomized Trial
Lead sponsor
Unity Health Toronto
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2002
Completion date
May 31, 2005
Enrollment
45 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

contrast induced nephropathy, critically ill